These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 27650520)
1. Managing Scalp Psoriasis: An Evidence-Based Review. Wang TS; Tsai TF Am J Clin Dermatol; 2017 Feb; 18(1):17-43. PubMed ID: 27650520 [TBL] [Abstract][Full Text] [Related]
2. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation. Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy in psoriasis: an evidence-based review. Gustafson CJ; Watkins C; Hix E; Feldman SR Am J Clin Dermatol; 2013 Feb; 14(1):9-25. PubMed ID: 23329077 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents. Ighani A; Partridge ACR; Shear NH; Lynde C; Gulliver WP; Sibbald C; Fleming P J Cutan Med Surg; 2019; 23(2):204-221. PubMed ID: 30463416 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial. Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259 [TBL] [Abstract][Full Text] [Related]
6. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp. McCormack PL Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117 [TBL] [Abstract][Full Text] [Related]
7. Topical treatments for scalp psoriasis. Warren RB; Brown BC; Griffiths CE Drugs; 2008; 68(16):2293-302. PubMed ID: 18973394 [TBL] [Abstract][Full Text] [Related]
8. In touch with psoriasis: topical treatments and current guidelines. Murphy G; Reich K J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077 [TBL] [Abstract][Full Text] [Related]
9. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. Girolomoni G; Vena GA; Ayala F; Cannavò SP; De Pità O; Chimenti S; Peserico A G Ital Dermatol Venereol; 2012 Dec; 147(6):609-24. PubMed ID: 23149707 [TBL] [Abstract][Full Text] [Related]
10. An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis. Soni B; Shivgotra R; Trehan K; Chhina A; Saini M; Jain SK; Thakur S Curr Drug Targets; 2024; 25(5):353-373. PubMed ID: 38500274 [TBL] [Abstract][Full Text] [Related]
11. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction. Freeman K Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834 [TBL] [Abstract][Full Text] [Related]
12. Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp. Kragballe K; van de Kerkhof P J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():10-21. PubMed ID: 24684739 [TBL] [Abstract][Full Text] [Related]
13. Scalp psoriasis: an overview of the disease and available therapies. Crowley J J Drugs Dermatol; 2010 Aug; 9(8):912-8. PubMed ID: 20684141 [TBL] [Abstract][Full Text] [Related]
14. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation. Jemec GB; van de Kerkhof PC; Enevold A; Ganslandt C J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):27-32. PubMed ID: 20456557 [TBL] [Abstract][Full Text] [Related]
15. Psoriasis: state of the art 2013. de la Brassinne M; Nikkels A Acta Clin Belg; 2013; 68(6):433-41. PubMed ID: 24635331 [TBL] [Abstract][Full Text] [Related]
16. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study. Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448 [TBL] [Abstract][Full Text] [Related]
17. Biologics in pediatric psoriasis - efficacy and safety. Dogra S; Mahajan R Expert Opin Drug Saf; 2018 Jan; 17(1):9-16. PubMed ID: 29022425 [TBL] [Abstract][Full Text] [Related]
18. Recommendations for a patient-centered approach to the assessment and treatment of scalp psoriasis: a consensus statement from the Asia Scalp Psoriasis Study Group. Frez ML; Asawanonda P; Gunasekara C; Koh C; Loo S; Oon HH; Thai VH; Tsai TF; Youn SW J Dermatolog Treat; 2014 Feb; 25(1):38-45. PubMed ID: 23083439 [TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of psoriasis vulgaris treatments: analysis of treatment with topical corticosteroid and/or vitamin D3 analog, oral cyclosporin, etretinate and phototherapy over a 35-year period, 1975-2010. Akasaka E; Mabuchi T; Manabe Y; Yahagi E; Yamada-Hiruma A; Yamaoka H; Kojima T; Kato M; Ikoma N; Ozawa A; Haruki Y J Dermatol; 2013 Apr; 40(4):238-43. PubMed ID: 23330814 [TBL] [Abstract][Full Text] [Related]
20. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options. Neri L; Miracapillo A G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]